Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Kinase inhibition--a new approach to the treatment of rheumatoid arthritis.

× No keyword cloud information.

9 in total

Review 1. Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.

Authors: Johan Kreuger; Mia Phillipson
Journal: Nat Rev Drug Discov Date: 2015-11-27 Impact factor: 84.694

2. Regulation of Transforming Growth Factor β-Activated Kinase Activation by Epigallocatechin-3-Gallate in Rheumatoid Arthritis Synovial Fibroblasts: Suppression of K(63) -Linked Autoubiquitination of Tumor Necrosis Factor Receptor-Associated Factor 6.

Authors: Anil K Singh; Sadiq Umar; Sharayah Riegsecker; Mukesh Chourasia; Salahuddin Ahmed
Journal: Arthritis Rheumatol Date: 2016-02 Impact factor: 10.995

3. Remission of rheumatoid arthritis on brentuximab vedotin.

Authors: Pankit Vachhani; Nilanjana Bose; James P Brodeur; Beata Holkova; Prithviraj Bose
Journal: Rheumatology (Oxford) Date: 2014-09-18 Impact factor: 7.580

4. Janus kinase 1/3 signaling pathways are key initiators of TH2 differentiation and lung allergic responses.

Authors: Shigeru Ashino; Katsuyuki Takeda; Hui Li; Vanessa Taylor; Anthony Joetham; Polly R Pine; Erwin W Gelfand
Journal: J Allergy Clin Immunol Date: 2013-12-22 Impact factor: 10.793

5. [Personalized medicine in cytokine-targeted therapy].

Authors: F Behrens; M Köhm
Journal: Z Rheumatol Date: 2013-02 Impact factor: 1.372

Review 6. Anti-inflammatory therapy in chronic disease: challenges and opportunities.

Authors: Ira Tabas; Christopher K Glass
Journal: Science Date: 2013-01-11 Impact factor: 47.728

7. Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study.

Authors: Anton Wulf Christensen; Simon Tarp; Daniel E Furst; Anna Døssing; Kirstine Amris; Henning Bliddal; Peter C Taylor; Robin Christensen
Journal: PLoS One Date: 2015-09-11 Impact factor: 3.240

Review 8. Efficacy and safety of tofacitinib in the treatment of rheumatoid arthritis: a systematic review and meta-analysis.

Authors: Ying He; Angel Y S Wong; Esther W Chan; Wallis C Y Lau; Kenneth K C Man; Celine S L Chui; Alan J Worsley; Ian C K Wong
Journal: BMC Musculoskelet Disord Date: 2013-10-18 Impact factor: 2.362

Review 9. JAK inhibitors: treatment efficacy and safety profile in patients with psoriasis.

Authors: Leeyen Hsu; April W Armstrong
Journal: J Immunol Res Date: 2014-05-05 Impact factor: 4.818

9 in total